pharma · Anemia · Anemia Associated With Chronic Kidney Disease · AKBA
Akebia Europe
Akebia Europe Limited
Akebia Europe is a pharma organization headquartered in Cambridge, USA. It trades on NYSE under ticker AKBA. Primary therapeutic focus areas include Anemia, Anemia Associated With Chronic Kidney Disease, Anemia of Chroni
Cambridge, USA HQ
2007 Founded
271 Employees
Public company Type
AKBA · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2007
- Employees
- 271
- Programs
- 25
- Drugs
- 13
- Patents
- 28
Ferric Citrate 1 GM Oral Tablet [AURYXIA]
Phase 3 · small molecule · Anemia, Iron Deficiency
Ferric Citrate 1 GM Oral Tablet [AURYXIA] for Anemia, Iron Deficiency is a Phase 3 program (small_molecule) at Akebia Europe Limited with 1 ClinicalTrials.gov record(s).
Internal code USRC-2021-002
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Akebia Europe Limited
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Anemia, Iron Deficiency
- Status
- completed
- Trials
- 1